IPO of Zentiva should be completed by the end of June

Komentář
Investiční bankovnictví KB

      IPO of pharmaceutical company Zentiva should be reportedly completed by the end of June, Reuters reported depending of investors’ interest. Price range for the offering should be set until mid June. Free float could reach 30%.

       We expect strong investors’ interest in the IPO. Pharmaceutical sector is defensive and therefore good fit for portfolios. In case of successful IPO, we expect Zentiva’s share to be traded in blue-chip SPAD segment.

      Tyto zprávy pro vás vytváří Investiční bankovnictví KB.